Search results for: 'system cell'

Eye diseases such as glaucoma, age-related macular degeneration, diabetic retinopathy, and macular edema require continuous monitoring of eye health, as they can be treated if detected early, but if left undetected, it can silently and rapidly progress to irreversible loss of vision. Home-based ophthalmic monitoring solutions can help in preventin...

Full product development IVD CMO comprises companies that partner with OEMs and support them in the development of IVD devices, ranging from concept to commercialization. IVD companies are continuously looking at new ways to optimize resources due to rising cost pressures and regulatory complexities, prompting industry participants to adopt innovat...

High prevalence of complex diseases, high investments and low success rate associated with drug development, are making the health industry appeal for innovative technologies that can enhance understanding of complex diseases, contribute to the development of personalized treatments, accelerate clinical trial activities, and lower the R&D expenditu...

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...

25 Mar 2022  |  North America  |  Frost Radar

Frost Radar™: North American Clinical Documentation Improvement Market, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Clinical documentation improvement (CDI), a vital mechanism in documenting care in the healthcare space, is a strategic necessity that goes beyond a component in the broader revenue cycle management (RCM) of claims processing. It focuses on improved patient outcomes, supports data quality that tells an accurate story of the patient’s care, facilita...

25 Apr 2022  |  North America  |  Frost Radar

Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phase...

23 Aug 2022  |  North America  |  Frost Radar

Frost Radar™: US Liquid Biopsy, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

The oncology space is maturing rapidly. With the arrival of blood-based assays for cancer screening and the emphasis on early detection, the liquid biopsy segment is seeing increased consolidation and high-impact acquisitions, such as Illumina and GRAIL, Exact Sciences and Thrive Earlier Detection, and Roche Foundation Medicine and Lexent Bio. Comp...

Predictive genetic testing (PGT) comprises analysis of genes, the whole genome, or exomes to predict the risk of a wide range of disorders. It can have long-term implications in preventive healthcare practices, including delayed onset of disease, treatment management, pharmacogenomics, and general wellness. One outcome of the COVID-19 pandemic has ...

Digital biomarkers play a crucial role in early disease detection and prevention; data-driven insights generated by wearable support early diagnosis, real-time monitoring of patient health, precise healthcare delivery, remote patient monitoring, and advanced R&D effort in the treatment of neurodegenerative conditions. While innovation focuses on th...